Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

A urticaria rash can either be a nonimmune response to ... antihistamines or topical corticosteroids for more severe or painful reactions. People with immunological urticaria should note how ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

more frequently observed in patients on Dupixent compared to placebo was injection site reactions. “CSU patients with uncontrolled disease experience highly burdensome itch and hives that can ...

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) to treat adults and ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

According to Doctor Michael, you might have heard the mysterious rash be called 'hives' before ... a bee or something you've eaten, like an allergic reaction. Doctor Michael continued explaining ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in patients ages 12 and older with CSU.